SELENOO: A Potential Drug Target and Biomarker for Mitochondrial Function

Target Name: SELENOO

NCBI ID: G83642

SELENOO

SELENOO: A Potential Drug Target and Biomarker for Mitochondrial Function

Introduction

Mitochondria are organelles responsible for generating energy in the form of ATP in cells throughout the body. They are also involved in the production of various molecules, including proteins, lipids, and carbohydrates. One of the proteins produced by mitochondria is called Selenoo (Protein adenylyltransferase selO, mitochondrial), which plays a crucial role in the transfer of adenosine, a molecule that carries energy from the mitochondria to the cytoplasm.

Selenoo is a key protein that helps regulate the transfer of adenosine from the mitochondria to the cytoplasm. It does this by catalyzing the transfer of adenosine to the cytoplasmic side of the mitochondrial inner mitochondrial membrane. This process is called transport export, and it is a critical step in the production of ATP by the mitochondria.

Selenoo is also involved in the regulation of mitochondrial dynamics and in the detoxification of foreign substances. It helps to maintain the stability of the mitochondrial environment and protects the mitochondria from damage caused by foreign particles.

Potential Drug Target

The potential drug target for Selenoo is related to the regulation of mitochondrial function and the production of ATP. drugs that target Selenoo and modulate its activity may have therapeutic benefits for a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One of the potential drug targets for Selenoo is the inhibition of the export of adenosine from the mitochondria. This could lead to an increase in the levels of adenosine in the cytoplasm and enhance the production of ATP by the mitochondria. This could have therapeutic benefits for diseases that are characterized by mitochondrial dysfunction, such as cancer, neurodegenerative diseases, and cardiovascular diseases.

Another potential drug target for Selenoo is the modulation of mitochondrial dynamics. Mitochondrial dysfunction is a condition in which the mitochondria are not able to function properly, leading to a variety of diseases. The export of adenosine from the mitochondria is a critical step in the regulation of mitochondrial dynamics, and drugs that can modulate this process may have therapeutic benefits for diseases characterized by mitochondrial dysfunction, such as cancer, neurodegenerative diseases, and cardiovascular diseases.

Biomarker

Selenoo is also potential biomarker for some diseases. The levels of Selenoo in the mitochondria can be affected by a variety of factors, including the levels of ATP, the cytoplasmic environment, and the levels of foreign particles in the mitochondria. also be affected by the levels of other proteins and molecules in the mitochondria, such as the levels of ubiquitin and sodium azide.

Selenoo has been shown to be involved in the regulation of the cytoplasmic environment in the mitochondria. It helps to maintain the stability of the mitochondrial environment and protects the mitochondria from damage caused by foreign particles. In addition, Selenoo has been shown to play a role in the detoxification of foreign substances in the mitochondria.

Conclusion

Selenoo is a protein that is involved in the regulation of mitochondrial function and the production of ATP. It is a potential drug target for diseases characterized by mitochondrial dysfunction, such as cancer, neurodegenerative diseases, and cardiovascular diseases. It is also a potential biomarker for these diseases. Further research is needed to fully understand the role of Selenoo in the regulation of mitochondrial function and the production of ATP, as well as its potential as a drug target and biomarker.

Protein Name: Selenoprotein O

Functions: Catalyzes the transfer of adenosine 5'-monophosphate (AMP) to Ser, Thr and Tyr residues of target proteins (AMPylation) (PubMed:30270044). May be a redox-active mitochondrial selenoprotein which interacts with a redox target protein (PubMed:24751718)

The "SELENOO Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SELENOO comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets